Omron, InterCure jointly address UK hypertension market:
This article was originally published in Clinica
Executive Summary
Omron Healthcare, a UK-based subsidiary of Japanese sensing technology specialist, is teaming up with InterCure, the New York, US-based developer of the RESPeRATE device for lowering blood pressure, in a co-marketing effort aimed at the UK hypertension market. As part of the agreement, Omron will include product information about RESPeRATE in boxes of its M10i blood pressure monitors, while InterCure will provide information on Omron's product in its RESPeRATE packaging.